OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
Authors:
Open Access
- 15 February 2023
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (3) , 100939
Abstract
No abstract availableKeywords
Funding Information
- European Commission (675743)
- KWF Kankerbestrijding (UL 2015–7817)
- Leids Universitair Medisch Centrum
This publication has 84 references indexed in Scilit:
- Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterizationNature Biotechnology, 2013
- Biomarkers on melanoma patient T Cells associated with ipilimumab treatmentJournal of Translational Medicine, 2012
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretionImmunobiology, 2011
- In vivo Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer ImmunotherapyCancer Research, 2008
- Transcriptional regulator Id2 mediates CD8+ T cell immunityNature Immunology, 2006
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Negative regulation of T-cell adhesion and activation by CD43Nature, 1995
- Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott–Aldrich syndromeNature, 1991